NAGEL MICHAEL 4
4 · Kiromic Biopharma, Inc. · Filed Oct 6, 2023
Insider Transaction Report
Form 4
NAGEL MICHAEL
Director
Transactions
- Award
Restricted Stock Units
2023-10-05+18,000→ 18,000 totalFrom: 2023-10-05→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU.